SESSION 2 – Artificial Intelligence and Machine Learning applied to drug development

SESSION 2 – Artificial Intelligence and Machine Learning applied to drug development

Thursday, September 19, 2024 10:45 AM to 11:30 AM · 45 min. (Europe/Zurich)
Ilmac Conference
Ilmac Lausanne

Information

This session will present case studies from key players (industry, startups, research) developing and making use of AI and ML innovations to optimise and accelerate drug development.

Loïc Roch | CEO | Atinary

Jo Varshney | CEO | VeriSim Life

Jean-Philippe Fricker | Chief Systems Architect | Cerebras

Raphëlle Luisier | Genomics & Health Informatics Group Lead | IDIAP Research Institute

Marion Bossy | Global Head of Real-World Evidence | SOPHiA GENETICS

Ilmac Highlights
Conference

Log in